Indoco Remedies Share Price

Indoco Remedies Limited is an India-based fully integrated, research-oriented pharmaceutical company. The Company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company caters to both Domestic and International markets. Its products include SENSODENT-K, HOMIDE, DEXOREN-S, LORCHEK-MR, SENSOFORM, KIDODENT, NINAF, KARVOL PLUS, CYCLOPAM, LIGNOX+ADRENLINE, NOXA, CITAL-UTI, RENOLEN, REXIDIN-M, CITAL, SENSODENT-KF, CARMICIDE, TOBAREN-DM, FEBREX PLUS, SCABEX, CLOBEN-G, MOFLOREN-BF, OTOREX, ZINCOREN, SENOLIN, LIGNOX, HEMSYL, FEDRIS, REXIDIN, VEPAN, OXIPOD, TURBOCORT, MACUCHEK, and DENTOGEL. The Company has around 11 manufacturing facilities, seven for finished dosage forms (FDFs) and four for active pharmaceutical ingredients (APIs), supported by a research and development center and a clinical research organization facility.As of 26 May 2026, Indoco Remedies share price is ₹195.74. The stock opened at ₹202.09, compared to its previous close of ₹199.08. During today's trading session, Indoco Remedies share price moved in the range of ₹194.99 to ₹202.92, with an average price of ₹198.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹194.99 and a high of ₹202.92. On the performance front, Indoco Remedies share price has declined by 23.22% over the last six months and is down 19.65% on a year-on-year basis.

The market capitalization of Indoco Remedies is ₹1,844 Crs, with a P/E ratio of -18.7 and a dividend yield of 0.10%.